Fortis Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Fortis Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,500	Closed	-$229K	–	290
2021 Q4	$229K	Hold	1,500	–	–	0.13%	95
2021 Q3	$243K	Sell	1,500 -550	-27%	-$92.6K	0.15%	84
2021 Q2	$335K	Buy	+2,050	New	+$316K	0.19%	74
2019 Q3	–	Sell	-465	Closed	-$51K	–	322
2019 Q2	$51K	Hold	465	–	–	0.02%	229
2019 Q1	$52K	Sell	465 -105	-18%	-$11.5K	0.03%	215
2018 Q4	$55K	Hold	570	–	–	0.03%	204
2018 Q3	$70K	Hold	570	–	–	0.04%	182
2018 Q2	$63K	Buy	570 +465	+443%	+$49.7K	0.04%	186
2018 Q1	$11K	Hold	105	–	–	0.01%	238
2017 Q4	$11K	Hold	105	–	–	0.01%	230
2017 Q3	$12K	Buy	+105	New	+$11.2K	0.01%	228

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fortis Advisors's IBB Position: Q1 2022 in Review

Fortis Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,500 shares — an estimated $229K sold.

Fortis Advisors first reported a position in IBB in Q3 2017 and held it in 11 quarters. The position peaked at $335K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Fortis Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Fortis Advisors sold 1,500 iShares Biotechnology ETF shares in Q1 2022, an estimated $229K.
Fortis Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 11 quarters.
Fortis Advisors's iShares Biotechnology ETF position peaked at $335K in Q2 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Fortis Advisors's 13F filing for Q1 2022, filed 16 May 2022.